FAYEZ SAROFIM & CO – AbbVie Inc. Transaction History
FAYEZ SAROFIM & CO portfolio value:
$295.56M
portfolio value
FAYEZ SAROFIM & CO quarter portfolio value change:
-12.37%
quarter
AbbVie Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -0.21% | -4.71K shares | -42.45M | $134.21 | 2.20M |
Q2 2022 | share | Decrease | -0.40% | -8.97K shares | -21.20M | $153.16 | 2.20M |
Q1 2022 | share | Increase | +0.37% | 8.11K shares | 60.28M | $162.11 | 2.21M |
Q4 2021 | share | Increase | +0.62% | 13.67K shares | 62.25M | $135.93 | 2.20M |
Q3 2021 | share | Decrease | -8.93% | -215.20K shares | -34.70M | $106.6 | 2.19M |
Q2 2021 | share | Decrease | -18.08% | -531.66K shares | -46.88M | $110.09 | 2.40M |
Q1 2021 | share | Decrease | -3.89% | -118.96K shares | -9.60M | $104.49 | 2.94M |
Q4 2020 | share | Decrease | -3.80% | -121.00K shares | 49.25M | $102.27 | 3.05M |
Q3 2020 | share | Decrease | -7.29% | -250.24K shares | -58.25M | $82.47 | 3.18M |
Q2 2020 | share | Increase | +12.63% | 384.87K shares | 104.77M | $91.35 | 3.43M |
Q1 2020 | share | Decrease | -4.60% | -146.77K shares | -50.61M | $69.88 | 3.04M |
Q4 2019 | share | Decrease | -2.90% | -95.36K shares | 33.71M | $80.14 | 3.19M |
Q3 2019 | share | Decrease | -1.85% | -62.15K shares | 5.34M | $67.55 | 3.28M |
Q2 2019 | share | Decrease | -1.56% | -53.20K shares | -30.65M | $63.9 | 3.35M |
Q1 2019 | share | Decrease | -0.93% | -31.92K shares | -42.42M | $69.89 | 3.40M |
Q4 2018 | share | Decrease | -1.22% | -42.48K shares | -12.25M | $78.96 | 3.43M |
Q3 2018 | share | Decrease | -1.60% | -56.55K shares | 1.49M | $80.16 | 3.47M |
Q2 2018 | share | Decrease | -2.42% | -87.84K shares | -15.38M | $77.74 | 3.53M |
Q1 2018 | share | Increase | +1.27% | 45.29K shares | -3.08M | $78.6 | 3.62M |
Q4 2017 | share | Decrease | -3.49% | -129.54K shares | 16.57M | $79.74 | 3.57M |
Q3 2017 | share | Decrease | -0.09% | -3.26K shares | 60.37M | $72.76 | 3.70M |
Q2 2017 | share | Decrease | -2.40% | -91.37K shares | 21.31M | $58.85 | 3.71M |
Q1 2017 | share | Decrease | -9.55% | -401.42K shares | -15.48M | $52.36 | 3.80M |
Q4 2016 | share | Decrease | -4.11% | -180.09K shares | -13.31M | $49.8 | 4.20M |
Q3 2016 | share | Decrease | -2.82% | -127.38K shares | -3.06M | $49.69 | 4.38M |
Q2 2016 | share | Decrease | -0.08% | -3.71K shares | 21.59M | $48.35 | 4.51M |
Q1 2016 | share | Increase | +2.02% | 89.22K shares | -3.43M | $44.19 | 4.51M |